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The aim of this thesis was to evaluate use of custom-made orthopae-
dic shoes (OS), and to evaluate which factors are associated with use of 
OS. More specifically, the aim of this thesis was to answer the following 
six research questions: 
What is the frequency of use of OS three months after delivery of  1. 
 patients’ first-ever pair of OS?
Which factors of usability are associated with use three months   2. 
 after delivery of patients’ first-ever pair of OS?
What is the association between patients’ expectations on factors  3. 
 of usability and use three months after delivery of their first-ever  
 pair of OS?
What is the frequency of use of OS 1.5 years after delivery of   4. 
 patients’ first-ever pair of OS?
Which short-term outcomes of factors of usability are associated  5. 
 with use 1.5 years after delivery of patients’ first-ever pair of OS?
Which factors of usability are important for individual patients?6. 
Following the development of a questionnaire to measure use and 
usability of OS (Chapter 2), these research questions were answered in 
Chapters 3 to 6. In short, the answers to these questions were:
Three months after the delivery of patients’ first-ever pair of OS,   1. 
 81% of the patients used their OS frequently (4-7 days/week),   
 13% used their OS occasionally (1-3 days/week), and 6% of the   
 patients did not use their OS at all (Chapter 3)
All evaluated factors of usability were associated with use of OS.  2. 
 Patients with a positive opinion on factors in all domains of us  
 ability (i.e. effectiveness, efficiency, and satisfaction) were more   
 likely to use their OS three months after delivery of their first-  
 ever pair than patients with a more negative opinion (Chapter 3).
Patients whose expectations were met by their experiences were   3. 
 more likely to use their OS three months after delivery of their   
 first-ever pair of OS (Chapter 4).
One and a half years after delivery of patients’ first-ever pair of   4. 
 OS, 87% of the patients still used their OS, whereas 13% of the   
 patients ceased using their OS (Chapter 5).
Patients with worse short-term outcomes, especially with the fit   5. 

























 likely to cease using their OS long-term (Chapter 5).
An improvement of walking was the most important factor of   6. 
 usability of OS for individual patients (Chapter 6).
The aim of this chapter is to integrate the results according to the 
theoretical framework as presented in Chapter 1, to discuss limitations of 
the research of this thesis that have not yet been discussed in Chapters 2 to 
6, and to discuss the implications of the research of this thesis for future 
research and clinical practice.
7.1 – Integration of the results of this thesis
In Chapter 1, models for assistive technologies (AT) in general were 
discussed, and the ‘Conceptual model for predicting assistive technology 
usage’ from Lenker and Jutai23 (Figure 1) was introduced as a theoreti-




















by applying them to that conceptual model in two steps. First, a tenta-
tive model of this thesis will be developed (Figure 2), which will then be 
modified into the final model of this thesis (Figure 3). 
AT usage is the main outcome measure of the conceptual model 
(Figure 1), which becomes use of OS in the tentative model of this the-
sis (Figure 2). Use of OS is a prerequisite for a patient to benefit from a 
pair of OS. When a pair of OS is being used, this will have an impact on 
the patient. In the conceptual model, this can be seen in the impact of AT 
(Figure 1). According to the conceptual model, AT have an impact on 
usability and quality of life. The association between use and usability 
of OS was evaluated in Chapter 3. An association was found between use 
and all evaluated factors of usability. All these factors will be filled in the 
impact of OS in the tentative model of this thesis (Figure 2). This will be 
elaborated when discussing the final model of this thesis. Quality of life 
was not the subject of the research of this thesis, nor has it been of any re-

































of OS could be neither falsified nor verified, quality of life was kept in the 
tentative model of this thesis (Figure 2). 
According to the conceptual model, AT usage can be predicted with 
the Perceived relative advantage (Figure 1). The perceived relative advantage is 
determined by weighing the perceived benefits of AT and perceived benefits 
of parallel intervention options (which may also be no intervention at all). 
Crucial to this is the word perceived, which stresses that the benefits of 
AT are of a subjective nature. Two patients with the same benefits may 
have a complete different perception of these, which in turn has a differ-
ent influence on their AT usage. For example, two patients both indicate 
they have ‘less pain when walking with OS’. However, one patient may 
perceive this as a great benefit, as they expected hardly any change at all. 





















that all their pain would be gone. The influence of patients’ expectations 
on use of OS was shown in Chapter 4. Patients whose expectations on 
factors of usability of OS were met by their experiences were more likely 
to use their OS. These factors of usability will be filled in in the perceived 
relative advantages in the tentative model of this thesis (Figure 2).
According to the conceptual model, the decision to use AT is recur-
ring23. The findings of our long-term follow-up study (Chapter 5) under-
line this recurrence of the decision to use OS. Changes were found in pa-
tients’ decision to use OS between short-term and long-term evaluations, 
with some patients using their OS more frequently and others using their 
OS less frequently or not at all at long-term follow-up.
In the tentative model of this thesis, all factors of usability were filled 
in the impact of OS and perceived relative advantages (Figure 2). However, 
considerable variation was found in patients’ opinion on these factors of 
usability within the groups of frequent use, occasional use and non-use 
(see Chapters 3 to 5). This indicates that large individual differences exist, 
and implies that not all factors of usability in the tentative model of this 
thesis were important for individual patients. 
A qualitative study was performed to gain further insight into the 
factors of usability that were important for individual patients, and the 
influence of these factors on a patient’s decision to use OS (Chapter 6). 
The results were twofold. No individual differences were found with 
the patients’ opinion on what was most important: an improvement of 
walking. The separate factors of usability in the domain effectiveness 
(reduction of pain, reduction of sprains, prevention of wounds) and the 
factors concerned with discomfort in the domain efficiency (fit of OS, 
ease of walking with OS) were seen by all patients as a prerequisite for 
an improvement of walking. Therefore, this will be changed in the impact 
of OS and perceived relative advantage of OS in the final model of this thesis 
(Figure 3). 
Whilst no difference in importance was found for an improvement of 
walking, individual differences were found in the importance attached 
to other factors of usability. For example, the cosmetic appearance of 
OS was important for some patients, yet not for others. Such individual 
differences were irrespective of age, gender, or pathology29,38. With this 
finding, the two remaining factors in the domain efficiency (donning/
doffing OS and weight of OS, together described by patients as ‘ease of 
use’) and cosmetic appearance (domain satisfaction) will remain in the 
impact of OS and perceived relative advantage of OS in the final model of this 
thesis (Figure 3). 

























orthopaedic shoe technician) was classified in the usability domain of sat-
isfaction in the tentative model of this thesis (Figure 2). However, a dis-
tinction can be made within this domain, between i) satisfaction with OS 
(which is part of the concept usability); and ii) satisfaction with services 
(which is distinct from the concept usability)10,11. This distinction could be 
seen in patients’ opinion as described in Chapter 6. Communication with 
prescribing clinicians was said to influence their satisfaction; however, 
it did not directly influence a patient’s decision to use their OS or not. 
Because communication with the prescribing clinicians was not directly 
linked with use of OS, it was removed from the impact of OS and perceived 
relative advantage of OS, and transferred to the contextual factors in the final 
model of this thesis (Figure 3).
According to patients in the qualitative study, acceptance influenced 
their decision to use OS (Chapter 6). The main barrier in acceptance of 
OS was their visibility, with OS seen as the visible representation of the 
patient’s disability. This is in line with research concerning AT in general, 
where has been stressed that patients who have accepted their disabil-
ity are more likely to use their AT32,37,38. Therefore, acceptance of OS was 
added to the final model of this thesis (Figure 3). 
The final model of this thesis is shown in Figure 3. Use of OS is 
influenced by the acceptance of OS. Acceptance of OS is influenced by the 
perceived relative advantage of OS and by contextual factors. The perceived 
relative advantage of OS is determined by weighing the oerceived benefits 
of OS and perceived benefits of parallel intervention options on three factors 
of usability that may be important for an individual patient (improve-
ment of walking, cosmetic appearance, ease of use) and on quality of life. 
Contextual factors include communication and service of prescribing clini-
cians, and influence acceptance of OS, thereby indirectly influencing use of 
OS. When OS are being used, the impact of OS is determined by outcomes 
of the three factors of usability that may be important for individual pa-
tients. The impact of OS determines the perceived benefits. The perception 
of these benefits is weighed against the perceived benefits of parallel treat-
ment options, to determine again the perceived relative advantage. With that, 
the decision to use OS or not is recurring.
7.2 – Limitations of the research of this thesis
7.2.1 – Limitations in selection of patients and information provided by 
patients
A selection bias may have occurred during distribution of the Monitor 
Orthopaedic Shoes (MOS). MOS was provided to patients by orthopaedic 










taken. A procedure whereby all patients would be selected from com-
pany databases, without provision of MOS by orthopaedic shoe techni-
cians, was not possible because of privacy regulations. It is possible that 
the orthopaedic shoe technicians only gave MOS to patients who they 
felt were more likely to use their OS and therefore be more likely to have 
a positive opinion on factors of usability. If such a selection bias would 
have occurred, use of OS and patients’ opinion on factors of usability 
would have been overestimated. However, orthopaedic shoe technicians 
provided MOS approximately three months before delivery of OS, thus 
they had no way of knowing whether patients were going to use their OS 
or not. Predicting use of OS and patients’ opinion on factors of usability 
three months before delivery is very difficult. When questioned after the 
research period, orthopaedic shoe technicians affirmed they had pro-
vided MOS to all eligible patients, without selection. This was verified 
by comparing the characteristics of patients who received MOS to the 
characteristics of all patients to whom a pair of OS was distributed in the 
same period, with similar characteristics found (see Chapters 3 and 4). A 
selection bias from non-response has been discussed in Chapters 3 and 4. 
Although a selection bias due to the procedures of the research could not 
be ruled out, it is unlikely that this bias has had a major influence on the 
results.
Patients who did not receive a final pair of OS were excluded, which 
could also cause a potential selection bias. It was legitimate to exclude 
these patients in our evaluation of use of OS, as they did not receive 
any OS. However, it would be interesting to evaluate the frequency of 
patients who did not receive a pair of OS after having them prescribed, 
and the reasons for not receiving a pair of OS. Clinically, it is important 
to know whether these patients received medical treatment or another 
AT for their foot problems (e.g. surgery or an ankle-foot orthosis), or 
went home dissatisfied with their unfinished OS, without returning for 
medical treatment.
An information bias may have occurred from social desirability in 
answering tendencies36. It has been suggested that in clinical practice 
patients’ indications of their frequency of use are sometimes not in ac-
cordance with the prescribing clinicians’ observations of signs of wear-
ing-out of their OS. In that situation, however, patients have to answer 
directly to their prescribing clinicians, which is more likely to result in 
socially desirable answers36. In our research, it was made clear to pa-
tients that all answers were confidential and would never be provided to 
their prescribing clinicians. The outright negative comments from some 

























from patients that the research was performed independently of the 
companies, suggest that it was clear for patients that their answers would 
not be provided to their prescribing clinicians. The potential for social 
desirability in answering tendencies was thereby minimized.
Another information bias that may have occurred is a recall bias36. 
In the post-part of MOS, patients were asked if their pain and sprains 
were much less or much more than before OS, requiring them to recall 
and compare to their earlier state. Rather than including a recall element 
in the question, the difference between the questions ‘how much pain/
sprains do you have?’ in the pre-part and post-part of MOS could have 
been calculated directly. It can be argued that calculating the difference 
is a less biased method, as no recall is included. However, that method 
does not take a possible ‘response shift’ into account34,35. Over time, 
the meaning of self-reported constructs is subject to change, because of 
recalibration, reprioritization, and reconceptualization34,35. This means 
that a score on a visual analogue scale may have a different meaning 
when scored six months later. The subjective experience of a change in 
pain may be better captured by directly evaluating the change retro-
spectively26,34,35. In line with current developments in research regarding 
response shift, a ‘then-test’ question with correction for recall bias would 
be a valuable future addition to MOS25.
7.2.2 – Limitations in evaluating use of custom-made orthopaedic shoes
The first limitation in evaluating use of OS is the lack of an objective 
measuring instrument. Evaluating use of OS by means of a questionnaire 
as MOS is subjective. An electronic device to objectively evaluate the fre-
quency and duration of use of OS would be an important improvement 
in research. Such a device should not interfere with patients’ normal 
daily life, and should therefore be light and not visible. The best option 
seems to be inserting such a device in the sole of OS, for example similar 
to the Nike + i-Pod sports kit1. Validation research is needed before such 
a device can be applied to use of OS.
A second limitation of evaluating use of OS in the research of this the-
sis was not taking the specific goal or task for which OS were prescribed 
into account. Use was classified by frequency in days per week. This 
method was suitable to compare all patients, irrespective of their specific 
situation, however, it may have lead to false negatives or false positives. 
A false negative may occur when a patient receives a pair of OS specifi-
cally for his occupation, and uses them always during work. However, 
they only work three days per week, and will be classified in the category 










to be, yet classified as occasional use only. A false positive may occur 
when a patient receives a pair of OS to be used all day, yet uses them 
only for a short duration on some days of the week, because they are dis-
satisfied with the cosmetic appearance. When they still use their OS four 
days per week, they are classified in the category frequent use. In that 
situation, OS are not used as intended, yet still classified as frequent use.
The magnitude of false negatives and false positives cannot be reli-
ably estimated. However, the duration of use gives an indication, as ex-
emplified in the previous paragraph. It was found that patients classified 
in the category frequent use have a significant longer daily duration of 
use than patients classified in the category occasional use, both at short-
term as well as long-term (see Tables 1 of Chapters 3 and 5). It is therefore 
unlikely that there were many false negatives or false positives in the 
research of this thesis. However, for an accurate estimation of false nega-
tives and false positives, and for a more detailed evaluation of use of OS, 
more information on the goal or task of OS is needed in future research.
A solution to minimizing false negatives and false positives, with-
out having to include specific and individual information on goal or 
task, may be a more subjective definition of use. This was proposed by 
Scherer31, who distinguishes optimal use and partial or reluctant use. 
Optimal use is defined as ‘goal achieved with no pain, fatigue, or stress’, 
and ‘safe, reliable, and easy to use’31. Partial or reluctant use is defined 
as ‘goal not fully achieved or achieved with discomfort and strain’, and 
‘device is inefficient’31. However, the problem with this distinction is that 
optimal and partial or reluctant are defined as two extremes, and it can 
be expected that a large number of patients will be found in between 
these extremes. In addition, no research has been performed to validate 
this definition of use. A more subjective definition of use is currently not 
suitable for research on use of OS.
7.2.3 – Limitations of the concept usability as outcome measure
All evaluated factors of usability (e.g. a change in pain after OS, ease 
of walking with OS, and the cosmetic appearance of OS) were associated 
with use of OS (Chapter 3). This seems to indicate that all these factors 
partially determine usability of OS. However, usability is not a static 
concept that resides within a product18. Rather, usability comprises many 
factors that can be defined within three domains: effectiveness, efficiency, 
and satisfaction. A limitation of the concept usability is that these factors 
can not be added up or combined into one score on usability. Only the 


























The separate factors of usability are an important outcome measure 
for AT, found to be present in more than 70% of the research on AT out-
comes24. However, these factors have been evaluated mainly with unpub-
lished or non-specific questionnaires24. Only three measuring instruments 
that capture the most relevant factors of usability were found in the 
literature, all developed for a specific AT: the Questionnaire for Usability 
Evaluation16, the Usability Scale for Assistive Technology – Wheeled Mo-
bility or Computer Access7, and the Monitor Orthopaedic Shoes (Chapter 
2). Development of a single measuring instrument that captures the most 
relevant factors of usability and is applicable for a broad set of AT would 
be valuable for research in the field of AT13,24.
7.3 – Future research
After integrating the results of the research of this thesis into the final 
model of this thesis (Figure 3), three themes emerge that warrant future 
research.
1. Communication between patients and prescribing clinicians
2. The association between use of OS and psychosocial factors
3. Prediction of use of OS before delivery
7.3.1: Communication between patients and prescribing clinicians
Good communication between patients and their prescribing clini-
cians is essential with regard to use of OS. In particular, communication 
before the first-ever pair of OS is delivered (Chapters 4 and 6; 37,42). With 
good communication, prescribing clinicians may influence several factors 
before delivery of OS that are known to be associated with later use of 
OS. Communication is a prerequisite: to explore patients’ expectations 
and ensure that patients have realistic expectations (Chapter 4; 17,33,40); to 
explore patients’ preferences of OS (Chapter 6; 27,32,37,41,42); for patients to 
feel involved in the decision making process (Chapter 6; 15,17,21,28,32,39,42); and 
to explore whether a patient will accept their OS or not (Chapter 6; 32,37,38). 
However, little is known about what patients experience as good com-
munication with their prescribing clinicians concerning their OS.
Patients have indicated that communication was good if they felt their 
wishes and their need for information were taken into account, and if 
they had confidence in their prescribing clinicians (Chapter 6; 42). Howev-
er, large differences between patients were also shown as to what exactly 
was seen as good communication. Further, patients were interviewed 
after delivery of their OS in both studies, and their opinion on communi-
cation might be affected by the actual outcomes of their OS. Therefore, it 










group of patients who have not yet received their OS.
Secondly, it should be investigated if gaps exist in communication 
between patients and prescribing clinicians. For example, such gaps may 
be found in what prescribing clinicians consider good communication 
and what patients consider good communication, or what prescrib-
ing clinicians (are trying to) communicate and what patients actually 
perceive, or even what an orthopaedic shoe company communicates in 
their advertisement and what their orthopaedic shoe technicians com-
municate. When the results of this thesis were presented to prescribing 
clinicians, a large majority of them indicated they were already aware of 
what good communication was, and were trying to communicate accord-
ingly. However, that is only effective if the patients experience it as well. 
For example, male patient H (Chapter 6) said: 
“In the end, they essentially forced the orthopaedic shoes upon me”. 
This clearly shows that this patient did not experience that he could 
make his own choices. It is possible though, that his prescribing clini-
cians felt they had given him space to make his own choices. Gaps like 
this hinder good communication, and can influence use of OS. Future 
research should be performed to investigate the existence and frequency 
of these gaps in communication.
The last and most important part of future research into communica-
tion between patients and prescribing clinicians is to implement the find-
ings into clinical practice, and actually optimize communication between 
patients and prescribing clinicians. One possibility is to develop commu-
nication training for prescribing clinicians that is based on the findings 
of the research of this thesis as well as on the findings of future research 
as described above. After developing such training, its effect should be 
investigated by evaluating use of OS and patients’ satisfaction before and 
after prescribing clinicians receive the training. This training may then 
become part of the education of prescribing clinicians.
 
7.3.2: The association between use of custom-made orthopaedic shoes 
and psychosocial factors
Psychosocial factors (e.g. quality of life and subjective well-being) are 
important outcomes of AT, and are associated with use of AT23. For OS, 
quotes of patients can be found in qualitative research that point to an 
important psychosocial impact of OS. For example: 
“There were ever so many in Church that didn’t know I was a diabetic, 
until I started wearing this big shoe; you don’t want to broadcast it!17.
“I felt very tearful the first time I had the shoes…humiliated…I feel 

























“After a few weeks, it finally clicked. You have to accept it in your mind 
first, then later in your heart.” (Chapter 6). 
However, quantitative research on the psychosocial impact of OS is 
missing.
This is in contrast with research concerning AT in general, where psy-
chosocial factors have been described as ‘probably the most important 
outcome from a user’s perspective’23. In 1996, the Psychosocial Impact of 
Assistive Devices Scale (PIADS) was developed, a measuring instrument 
to assess the psychosocial impact of AT8,9,19. The PIADS assesses qual-
ity of life and subjective well-being, two psychosocial factors that have 
been used interchangeably in AT literature since8,9,19. The prominence of 
psychosocial factors in AT research, and their association with use of AT 
can be seen in current models14,23, and in the taxonomy of AT outcomes 
as proposed by the Consortium of Assistive Technology Outcomes Re-
search20.
The association between use of OS and psychosocial factors is an 
important theme for future research. The PIADS seems to be the best 
measuring instrument available for this type of research, although it has 
to be validated for the Dutch situation first. General (health-related) qual-
ity of life measuring instruments are less valid, as these are not sensitive 
enough to detect psychosocial changes specific to AT9,19. When the asso-
ciation between use of OS and psychosocial factors is known, the concep-
tual model (Figure 1) can be applied in whole to OS (Figure 3).
7.3.3.: Prediction of use of custom-made orthopaedic shoes before 
delivery
From the final model of this thesis (Figure 3) it follows that use of 
OS cannot be predicted without taking the impact of OS into account. 
That means that use of OS cannot be predicted before they are delivered. 
However, prediction of use before delivery is worthwhile, as it can save 
time, money, and energy for patients and prescribing clinicians. Whereas 
AT specific models have no predictive value, models from social science 
may offer a base for prediction of AT use22. After a review, two mod-
els were indicated that may predict AT use22: the Perceived Attributes 
Theory30, and the Theory of Planned Behaviour2,3 (TPB). As a last theme 
for future research, these two models will be applied to use of OS, and 
will be used to explore if use of OS might be predicted before delivery by 
future research based on these models.
7.3.3.1: Perceived attributes theory, part of diffusion of innovations










Diffusion of Innovations (DOI; Figure 4; 30). Initially, it may seem a rather 
long way from a model that deals with ‘the process by which an innova-
tion is communicated through certain channels among the members of a 
social system’30 to use of OS. Following, DOI will be explained, and at the 
same time applied to use of OS. 
The first element of DOI is an innovation, which is defined as ‘an idea, 
practice, or object that is perceived as new by an individual or other unit 
of adoption’30. OS were perceived as new objects by all patients who 
received their first-ever pair of OS. So with this definition, OS are an in-
novation.
The second element of DOI is the communication channel, which is 
defined as ‘the means by which messages get from one individual to an-
other’30. This process is further defined by stating that the first individual 
has knowledge of the innovation, whereas the second individual has not. 
For OS, two communication channels can be seen: i) between prescribing 
clinicians (with knowledge) and patients (without knowledge), and ii) 
between experienced patients (with knowledge) and inexperienced pa-
tients (without knowledge). Concerning the first communication channel, 
much has already been written on the importance of that in this thesis 
(see further section 7.3.1). The second communication channel also seems 
to be important in relation to use of OS. A new, previously unpublished, 

































other patients were only told by satisfied patients, for example:
Male pt. D: “A neighbour had also received orthopaedic shoes. She 
walks much better now.” 
Whereas negative stories were only told by dissatisfied patients, for 
example:
Female pt. I: “There is someone living close by, she has two pairs in the 
cupboard, can’t do anything with them. Her mother, same story.” 
The third element of DOI is time30. Time is involved in DOI in the 
innovation-decision process by which an individual passes from first 
knowledge to finally confirmation of the decision30 (Figure 4). Five stages 
are conceptualised: 
1. Knowledge: when a patient learns from the existence of OS. 
2. Persuasion: when a patient forms a favourable or unfavourable 
 attitude towards OS. 
3. Decision: when a patient decides to use OS or not. 
4. Implementation: when a patient uses OS. 
5. Confirmation: when a patient seeks reinforcement of their deci
 sion to use OS. At this stage, patients may reverse their previous 
 decision (e.g. from use to non-use, or from non-use to use; see 
 Chapter 5).
The fourth element of DOI is the social system30. Whereas the first 
three elements are discussed at the level of the individual, which makes 
them applicable to use of OS, the fourth element concerns innovations 
for an entire social system. As this is not applicable for OS (which are 
not prescribed for an entire social system), this will not be applied in this 
discussion.
Of the stages defined in the element time, the second stage (persua-
sion) is that which occurs before a patient makes the decision to use or 
not use OS. Information at this stage could be the basis for research to 
predict that decision. DOI explains this stage with the Perceived Attri-
butes Theory (Figure 4). According to DOI, a patient seeks information in 
this stage, and forms a favourable or unfavourable attitude towards OS. 
This attitude is determined by the factors of usability of OS, as perceived 
by the patient. According to DOI, an innovation has five perceived at-
tributes30 (Figure 4): 
1. Relative advantage: the degree to which OS are perceived as bet
 ter than other interventions (e.g. surgery or an ankle-foot ortho
 sis) or no intervention.
2. Compatibility: the degree to which OS are perceived as consis
 tent with existing values, past experiences, and needs. For ex










 ences of a patient who has always had just one or two pairs of 
 shoes, than with a patient who has at least twenty different pairs. 
 On the other hand, need is known to be associated with use32. If 
 the first patient receives OS to protect their feet from ulceration, 
 but does not perceive the need for that, compatibility with OS 
 may eventually be low; whereas the second patient might receive 
 OS to reduce the dreadful pain in their feet, making their com
 patibility very high.
3. Complexity: the degree to which OS are perceived to be easy or 
 difficult to use. The relation between donning/doffing OS and 
 the weight of OS with use of OS has been shown in the research 
 of this thesis.
4. Trialability: the degree to which OS may be experimented with 
 first. Some patients receive temporary OS first. This may per
 suade patients to use their future OS, as they may already experi
 ence the benefits. Some patients in the qualitative study indicat
 ed that it was very important for them to be able to try a tempo
 rary pair of OS first.
5. Observability: the degree to which the results of OS are visible to 
 others. Observability may be perceived as positive when it 
 concerns the visibility of an improvement of walking. Observ
 ability may be perceived as negative when patients have a nega
 tive opinion on the cosmetic appearance, or when patients see 
 their OS as visible representation of their disability. 
In order to predict use of OS with research based on DOI, patients’ 
perceptions on the five perceived attributes have to be assessed before 
delivery of OS. However, relative advantage, perceived complexity, trial-
ability, and observability are all very likely to be influenced by the impact 
of OS, and are best evaluated after delivery. The only attribute that seems 
to have potential to predict use of OS before delivery is compatibility, as 
patients’ values, past experiences and needs will be informative before 
delivery. 
Concluding, DOI seems an interesting model that might explain a 
patient’s decision to use OS or not. However, DOI seems to have limited 
possibilities in predicting use of OS before delivery.
7.3.3.2: The theory of planned behaviour
The second model is the Theory of Planned Behaviour (TPB)2,3,5 (Fig-
ure 5). This model has its origin in explaining and predicting social be-
haviour, such as voting, discriminating, cheating, and giving to charity3; 

























health-related behaviour such as using condoms, quitting smoking, and 
adhering to a low-fat diet6. The TPB will be briefly explained first, and 
then applied to use of OS.
According to the TPB, a person’s intention to perform a particular be-
haviour is stronger when the attitude towards that behaviour is more fa-
vourable, when the subjective norm with respect to the behaviour is more 
favourable, and when the perceived behavioural control over the behaviour 
is greater2,3,5 (Figure 5). An intention to perform the behaviour, in com-
bination with the perceived behavioural control over the behaviour, in turn 
predict the actual behaviour2,3,5. Attitudes, subjective norm, and perceived be-
havioural control are guided by an underlying foundation of beliefs about 
the behaviour: behavioural beliefs, normative beliefs, and control beliefs2-4. 
These beliefs will be applied to use of OS.
Behavioural beliefs are the subjective probability of the outcomes, and 
the importance attached to these outcomes2-4. For example, if a patient be-
lieves that it is very likely that use of OS will lead to an improvement of 
walking, and an improvement of walking is very important to them, they 
have strong behavioural beliefs, and will have a strong attitude towards use 
of OS. However, other outcomes can also play a role. If the same patient 
also believes that use of OS will lead to inconvenience with donning OS, 



















as will their attitude towards use of OS. A patient’s perception on all 
possible outcomes should be taken into account when investigating the 
behavioural beliefs that guide the attitude towards use of OS.
Normative beliefs are the perceived expectations of the opinion of 
important others on their use of OS, in combination with the motivation 
to comply with this opinion2-4. For example, if a patient expects that their 
children and grandchildren all think the OS should be used, and this pa-
tient is very motivated to comply with these opinions, they have strong 
normative beliefs, and will have a strong subjective norm on use of OS. 
However, if this patient expects that their neighbour will disapprove of 
their new OS, and the opinion of the neighbour is of even greater impor-
tance, the normative beliefs will be much lower, as will the subjective norm 
with respect to use of OS. A patient’s perception on the opinion of all 
important others should be taken into account to investigate the norma-
tive beliefs that guide the subjective norm with respect to use of OS.
Control beliefs are the perceived presence of factors that may facilitate 
or impede use of OS, in combination with the perceived control over 
these factors2-4. For example, if a patient expects that they will have to 
work long hours in the coming period, and their OS are well suited to 
their work, they will have strong control beliefs, and therefore a strong 
perceived behavioural control. However, if they also expect to spend a lot of 
time in, for example, the mosque or at home, and they are not supposed 
to use shoes in these places, their control beliefs will be lower, as will their 
perceived behavioural control on use of OS. A patient’s perception on all 
facilitating and impeding factors should be taken into account to investi-
gate the control beliefs that guide the perceived behavioural control.
In order to predict use of OS with research based on the TPB, a TPB 
questionnaire has to be developed4. Extensive manuals are available 
for the development4,12. With such a questionnaire, patients’ behavioural, 
normative, and control beliefs, as well as attitude towards the behaviour, 
subjective norm with respect to the behaviour, and perceived behavioural 
control can be assessed. All of these factors are relevant before actual 
delivery of OS, and all of these factors can be assessed without taking the 
impact of OS into account, which makes the TPB applicable in predicting 
use of OS. A possible limitation of applying this model to predict use of 
OS is that behaviour should be defined in terms of target, action, context, 
and time for construction of a TPB questionnaire4. Use of OS is a rather 
general definition that should be defined more specifically for every 
single patient before a patient can complete a TPB questionnaire. This 
might limit development of a generic questionnaire or generalization of 

























based on an individualized definition of use may be helpful in optimisa-
tion of prescription and manufacturing of OS. 
Concluding, the TPB seems to have good possibilities in predicting 
use of OS before delivery. Future research is needed to investigate these 
possibilities.
7.4 – Implications for clinical practice
To enhance use of OS and increase patients’ satisfaction, focus during 
prescribing and manufacturing of OS should be patient-centred, and not 
product-centred. With a product-centred focus, technically perfect OS 
may be manufactured; however, when patients’ preferences or expecta-
tions are not taken into account, these OS are not likely to be used. In 
contrast, with a patient-centred focus it can be ensured that patients’ 
preferences on factors of usability of OS have been taken into account, 
that patients have realistic expectations, and that patients accept their OS. 
As shown in this thesis, these are all essential factors in relation to use of 
OS. 
For a patient-centred focus, good communication between patients 
and prescribing clinicians is crucial. With good communication, the most 
optimal solution can be found taking patients’ preferences, expectations, 
and acceptance of their future OS into account. This, however, requires 
extra time, especially in the beginning of the process of prescribing and 
manufacturing OS. The challenges for clinical practice are to ensure good 
communication between patients and prescribing clinicians and to create 
that extra time, to fully implement a patient-centred focus when prescrib-
ing and manufacturing OS.
7.5 – Conclusions
The majority of patients who received a first-ever pair of OS used 
them frequently (4-7 days/week), both at short-term (three months after 
delivery), and at long-term (1.5 years after delivery). Patients who were 
using their OS more frequently had a more positive opinion on all the 
evaluated factors of usability of their OS. In addition, patients whose 
expectations were met by their experiences were more likely to use their 
OS. An improvement of walking was the only factor of usability that 
was important for all patients. Individual differences were found on the 
importance of other evaluated factors, irrespective of age, gender, or 
pathology.
A patient’s decision to use their OS is influenced by acceptance of 
OS. Patients are more likely to accept OS when the perceived advantages 










advantages of other options. The perceived advantages of OS depend on 
patients’ preferences, expectations, and experiences of factors of usability 
of OS. Communication and service of prescribing clinicians, as well as 
the opinion of others, can also influence acceptance of OS.
In clinical practice, a patient-centred focus is crucial. Good communi-
cation between patients and prescribing clinicians is needed, to find the 
most optimal solution taking into account patients’ preferences, expecta-
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